SINGAPORE (June 25): Maybank KimEng expects Japfa, the animal protein supplier, to return to the recovery path with FY18E-20E profit rising back up to US$89-116 million ($121-$158 million) levels from US$16 million in FY17.

“Japfa currently trades at 9x FY18E P/E while our SOTP based target price of $0.86 implies 14x FY18E P/E, a 13% discount to peers’ 16x,” says Maybank analyst John Cheong in an initiation report published last Thursday.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply


Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook